Abstract
Screening of inhibitor libraries for candidate ligands is an important step in the drug discovery process. Thermal denaturation-based screening strategies are built on the premise that a protein–ligand complex has an altered stability profile compared to the protein alone. As such, these assays provide an accessible and rapid methodology for stratifying ligands that directly engage with the protein target of interest. Here, we describe three denaturation-based strategies for examining protein–inhibitor binding, in the context of SH2 domains. This includes conventional dye-based Thermal Shift Assays (TSA), nonconventional labeled ligand-based TSA, and Cellular Thermal Shift Assays (CETSA). Conventional dye-based TSA reports on the fluorescence of an external hydrophobic dye as it interacts with heat-exposed nonpolar protein surfaces as the temperature is incrementally increased. By contrast, nonconventional-labeled ligand TSA involves a fluorescence-tagged probe (phosphopeptide for SH2 domains) that is quenched as it dissociates from the protein during the denaturation process. CETSA involves monitoring the presence of the protein via Western blotting as the temperature is increased. In all three approaches, performing the assay in the presence of a candidate ligand can alter the melting profile of the protein. These assays offer primary screening tools to examine SH2 domain inhibitors libraries with varying chemical motifs, and a subset of the advantages and limitations of each approach is also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niesen FH, Berglund H, Vedadi M (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2:2212–2221
Kranz JK, Schalk-Hihi C (2011) Protein thermal shifts to identify low molecular weight fragments. Methods Enzymol 493:277–298
Gao K, Oerlemans R, Groves MR (2020) Theory and applications of differential scanning fluorimetry in early-stage drug discovery. Biophys Rev 12(1):85–104
Redhead M, Satchell R, McCarthy C et al (2017) Thermal shift as an entropy-driven effect. Biochemistry 56:6187–6199
de Araujo ED, Orlova A, Neubauer HA et al (2019) Structural implications of STAT3 and STAT5 SH2 domain mutations. Cancers (Basel) 11:1757
Orlova A, Wagner C, De Araujo ED et al (2019) Direct targeting options for STAT3 and STAT5 in cancer. Cancers (Basel) 11:1930
de Araujo ED, Manaswiyoungkul P, Erdogan F et al (2019) A functional in vitro assay for screening inhibitors of STAT5B phosphorylation. J Pharm Biomed Anal 162:60–65
De Araujo ED, Kanelis V (2014) Successful development and use of a thermodynamic stability screen for optimizing the yield of nucleotide binding domains. Protein Expr Purif 103:38–47
Kosack L, Wingelhofer B, Popa A et al (2019) The ERBB-STAT3 axis drives Tasmanian devil facial tumor disease. Cancer Cell 35:125–139.e9
Molina DM, Jafari R, Ignatushchenko M et al (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science (80- ) 341:84–87
Jafari R, Almqvist H, Axelsson H et al (2014) The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9:2100–2122
Mahmood T, Yang PC (2012) Western blot: technique, theory, and trouble shooting. N Am J Med Sci 4:429–434
Delport A, Hewer R (2022) A superior loading control for the cellular thermal shift assay. Sci Rep 12:6672
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
Good NE, Winget GD, Winter W et al (1966) Hydrogen ion buffers for biological research. Biochemistry 5:467–477
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
de Araujo, E.D., Orlova, A., Ashraf, Q.F., Moriggl, R., Gunning, P.T. (2023). Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays. In: Carlomagno, T., Köhn, M. (eds) SH2 Domains. Methods in Molecular Biology, vol 2705. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3393-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3393-9_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3392-2
Online ISBN: 978-1-0716-3393-9
eBook Packages: Springer Protocols